Crinetics Pharmaceuticals, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 17.64 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 18.48M shares, a 6.03% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 17.43M shares, a 7.41% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 16.23M shares, a 28.59% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 12.62M shares, a 48.91% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 16.61M shares, a 9.28% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 15.20M shares, a 10.59% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 13.74M shares, a 33.05% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 10.33M shares, a 52.75% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.64M shares 10-Q · filed 2026-08-03 | |||||||
| 2026-03-31 | 18.48M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 16.61M shares 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | 17.35M shares 10-Q · filed 2025-11-06 | |||||||
| 2025-06-30 | 17.62M shares 10-Q · filed 2026-08-03 | 17.62M shares 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | 17.43M shares 10-Q · filed 2026-05-07 | 17.43M shares 10-Q · filed 2025-05-08 | ||||||
| 2024-12-31 | 15.20M shares 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | 15.53M shares 10-Q · filed 2025-11-06 | |||||||
| 2024-06-30 | 15.80M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 16.23M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 13.74M shares 10-K · filed 2026-02-26 | |||||||
| 2023-09-30 | 13.55M shares 10-Q · filed 2024-11-12 | |||||||
| 2023-06-30 | 13.53M shares 10-Q · filed 2024-08-08 | |||||||
| 2023-03-31 | 12.62M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 10.33M shares 10-K · filed 2025-02-27 | |||||||
| 2022-09-30 | 9.34M shares 10-Q · filed 2023-11-07 | 9.18M shares 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | 8.96M shares 10-Q · filed 2023-08-08 | 8.80M shares 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | 8.47M shares 10-Q · filed 2023-05-09 | 8.28M shares 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | 6.76M shares 10-K · filed 2024-02-28 | 6.55M shares 10-K · filed 2022-03-30 | ||||||
| 2021-09-30 | 6.61M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 6.15M shares 10-Q · filed 2022-08-12 | |||||||
| 2021-03-31 | 6.01M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 4.62M shares 10-K · filed 2023-02-28 | 4.44M shares 10-K · filed 2021-03-30 | ||||||
| 2020-09-30 | 4.24M shares 10-Q · filed 2021-11-05 | |||||||
| 2020-06-30 | 4.01M shares 10-Q · filed 2021-08-10 | |||||||
| 2020-03-31 | 3.90M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 3.16M shares 10-K · filed 2022-03-30 | |||||||
| 2019-09-30 | 3.15M shares 10-Q · filed 2020-11-06 | |||||||
| 2019-06-30 | 3.09M shares 10-Q · filed 2020-08-07 | |||||||
| 2019-03-31 | 3.01M shares 10-Q · filed 2020-05-08 | 3.01K shares 10-Q · filed 2019-05-13 | ||||||
| 2018-12-31 | 2.47M shares 10-K · filed 2021-03-30 | |||||||
| 2018-09-30 | 2.42M shares 10-Q · filed 2018-11-13 | 2.42M shares 10-Q · filed 2019-11-12 | 2.42M shares 10-Q · filed 2018-11-13 | |||||
| 2018-06-30 | 17.13M shares 10-Q · filed 2018-08-30 | 17.13M shares 10-Q · filed 2019-08-13 | 17.13M shares 10-Q · filed 2018-08-30 | |||||
| 2018-03-31 | 16.27K shares 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | 10.11M shares 10-K · filed 2020-03-09 | |||||||
| 2017-09-30 | 7.96M shares 10-Q · filed 2018-11-13 | 7.96M shares 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | 8.02M shares 10-Q · filed 2018-08-30 | 8.02M shares 10-Q · filed 2018-08-30 | ||||||
| 2016-12-31 | 6.92M shares 10-K · filed 2019-03-13 |